بررسی تاثیر قطره ی چشمی فلورومتولون بر میزان ایجاد عارضه فشار داخل چشم بعد از عمل PRK

Subject Areas : علوم پزشکی

Ladan Safarian Toosi ¹ (استادیار، دانشکده پزشکی، دانشگاه آزاد اسلامی مشهد، مشهد، ایران.)
Hamid Khakshor ² (استادیار، دانشکده پزشکی، دانشگاه آزاد اسلامی مشهد، مشهد، ایران.)
Mohammad reza Vojdani ³ (دانشجوی رشته پزشکی، دانشکده پزشکی، دانشگاه ازاد اسلامی مشهد، مشهد، ایران.)

Received: 2017-06-06 Accepted : 2017-06-06 Published : 2012-05-21

Keywords: Intraoccular pressure–Flurometholone-Photorefractive keratectomy,

Abstract :

Background and objective: Photorefractive keratectomy (PRK) is generally believed to be safe and effective for treatment of myopia. Steroid responders may develop elevated intraocular pressure (IOP) within a short time following steroid administration. This ocular hypertensive response to corticosteroids is an autosomal dominant trait found in one third of the general population. The current study was performed to evaluate the incidence of Flurometholone induced ocular hypertension following myopic PRK. Methods: PRK was performed on 400 eyes of 200 patients. Flurometholone was administered for first group %0.1 four times a day in first week each time one drop, 3 times a day for second week, 2 times for third week and one time a day for forth week. Second group received FML %0.1 for 3 months, first months 4 times, second month 3 times and third month 2 times a day each time one drop, Intraocular pressure (IOP) was measured preoperatively, after 1, 2 and 3 month(s) in both groups. Data was statistically analyzed using SPSS V21. Results: Mean age of first and second groups were 30.2± 5.58 and 30.2± 5.68 years respectively. 74 percent of first and 73% of second group were women. Mean IOP of right eyes preoperatively, after 1, 2 and 3 months were 15.1± 2.13, 15.5± 2.06 , 16.2±1.81 and 17.2±2.06 mmHg in group 1 respectively, and in group 2 , 15.4±2.04 , 15.8±1.98, 16.2±2.07 and 17.2± 2.08 mmHg respectively. IOP of left eyes in group 1 were 15.1±2.03, 15.5±1.98, 16.4±1.87 and 17.2±1.77 mmHg and in group 2 15.4±2.03, 15.9±1.95, 16.4±1.96 and 17.5±1.75 mmHg respectively. There was no difference between two groups considering IOP and also in details (men and women, 20-35 and 36-50 years) no significant differences was seen between two groups considering IOP in each time level (P>0.05). Conclusion: In this cohort, reducing regimens of FML proved to be a safe anti- inflammatory treatment in terms of avoiding corneal haze after PRK.  

References:

 

1. Vetrugno M, Marino A, Quaranta GM, Cardia L. A randomized , comparative study of Flurometholone 0/2 % and Flurometholone 0/1% acetate after Photorefractive keratectomy. Eur  J. Ophtalmol. 2000 Jan-Mar; 10(1):39-45.


2. Mifflin MD, Leishmann LL, Christiansen SM, Sikder S , Hsu M , Moshirfar M. Use of loteperdnol for routine Prophylaxis after Photorefractive keratectomy. clin ophtalmol. 2012; 6)5): 653-9.


3. Riordon-Eva P, Whitcher JP. Vaughan &Asburys general ophthalmology.18^th ed. New York : Langer; 2011. p . 254-273.


4. Hyman L. Myopic and hyperopic refractive error in adults: an overview. Ophthalmic Epidemiol. 2007 Jul-Aug; 14(4):192-7.


5. Shrestha S, Thapa M, Shah DN. Pattern of intraocular pressure fluctuation in uveitic eyes treated with corticosteroids. Ocul Immunol Inflamm. 2014 Apr;22(2):110-5.


6. Jain S, Thompson JR, Foot B, Tatham A, Eke T. Severe intraocular pressure rise following intravitreal triamcinolone: a national survey to estimate incidence and describe case profiles. Eye (Lond). 2014 Apr;28(4):399-401.


7. American Academy of Ophthalmology. Basic and Clinical Science course. Fundamentals and principles of ophthalmology . 7^th ed. San Francisco : American academy of ophthalmology; 2011-2012. Vol 2.p.127-133.


8. Ang M, Ti SE, Loh R, Farzavandi S, Zhang R, Tan D, Chan C. Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis. Clin Ophthalmol. 2012;6(11):1253-8.


9. Mataftsi A, Narang A, Moore W, Nischal KK. Do reducing regimens of fluorometholone for paediatric ocular surface disease cause glaucoma. Br J Ophthalmol. 2011 Nov;95(11):1531-3.


10. Javadi MA, Mirbabaei-Ghafghazi F, Mirzade M, Yazdani S, Yaseri M. Steroid induced ocular hypertension following myopic photorefractive keratectomy. J Ophthalmic Vis Res. 2008 Jan;3(1):42-6.


11. Fan DS, Yu CB, Chiu TY, Wong CY, Ng JS, Pang CP, Lam DS. Ocular-hypertensive and anti-inflammatory response to rimexolone therapy in children. Arch Ophthalmol. 2003 Dec;121(12):1716-21.


12. Fan DS, Ng JS, Lam DS. A prospective study on ocular hypertensive and antiinflammatory response to different dosages of fluorometholone in children. Ophthalmology. 2001 Nov;108(11):1973-7.


13. Deng Y, Wnag L, Liu C, Cai R. Effects of Dexamethasone, Fluorometholone and Florex on intraocular pressure after photorefractive keratectomy. Hua Xi Yi Ke Da Xue Xue Bao. 1999 Jun;30(2):205-7.
    
    
    1. Pang G, Wang Z, Zheng W, Wang W, Sun Y. Glucocorticoid-induced ocular hypertension after photorefractive keratectomy. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1995 Apr;17(2):115-9.
    
    
    2. Kim JH, Sah WJ, Hahn TW, Lee YC. Some problems after photorefractive keratectomy. J Refract Corneal Surg. 1994 Mar-Apr;10(2 Suppl):S226-30.